Jinyu Bio-Technology Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.018x

Jinyu Bio-Technology Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Jinyu Bio-Technology Co Ltd (600201) has a cash flow conversion efficiency ratio of 0.018x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥102.68 Million ≈ $15.03 Million USD) by net assets (CN¥5.65 Billion ≈ $827.18 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Jinyu Bio-Technology Co Ltd (1998–2025)

Cash flow conversion efficiency of Jinyu Bio-Technology Co Ltd from 1998 to 2025. This chart illustrates how Jinyu Bio-Technology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Jinyu Bio-Technology Co Ltd share price for real-time trading data and today's change.

Jinyu Bio-Technology Co Ltd Cash Flow Conversion Ratio Explained

Jinyu Bio-Technology Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Jinyu Bio-Technology Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jinyu Bio-Technology Co Ltd ranked by their cash flow conversion efficiency. Also see Jinyu Bio-Technology Co Ltd (600201) market capitalisation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Shenglan Technology Co Ltd
SHE:300843
-0.013x
Bukit Asam Tbk PT
JK:PTBA
0.101x
Dongfang Electronics Co Ltd
SHE:000682
0.033x
Sino-Platinum Metals Co Ltd
SHG:600459
-0.104x
Perrigo Company PLC
NYSE:PRGO
0.055x
Titan Wind Energy Suzhou
SHE:002531
0.018x
Innergex Renewable Energy Inc.
TO:INE
0.062x
MVV Energie AG
F:MVV1
-0.071x

Annual Cash Flow Conversion Efficiency for Jinyu Bio-Technology Co Ltd (1998–2025)

The table below shows the annual cash flow conversion efficiency of Jinyu Bio-Technology Co Ltd from 1998 to 2025. Review Jinyu Bio-Technology Co Ltd (600201) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥5.55 Billion
≈ $812.27 Million
CN¥316.12 Million
≈ $46.26 Million
0.057x +6.51%
2024-12-31 CN¥5.42 Billion
≈ $792.44 Million
CN¥289.55 Million
≈ $42.37 Million
0.053x -27.11%
2023-12-31 CN¥5.65 Billion
≈ $827.50 Million
CN¥414.83 Million
≈ $60.70 Million
0.073x +13.87%
2022-12-31 CN¥5.35 Billion
≈ $782.82 Million
CN¥344.65 Million
≈ $50.43 Million
0.064x -32.80%
2021-12-31 CN¥5.56 Billion
≈ $813.64 Million
CN¥533.08 Million
≈ $78.01 Million
0.096x -27.88%
2020-12-31 CN¥5.26 Billion
≈ $770.13 Million
CN¥699.61 Million
≈ $102.38 Million
0.133x +59.72%
2019-12-31 CN¥4.87 Billion
≈ $712.50 Million
CN¥405.24 Million
≈ $59.30 Million
0.083x +2.89%
2018-12-31 CN¥5.22 Billion
≈ $764.23 Million
CN¥422.46 Million
≈ $61.82 Million
0.081x -59.37%
2017-12-31 CN¥4.48 Billion
≈ $655.26 Million
CN¥891.44 Million
≈ $130.45 Million
0.199x -1.20%
2016-12-31 CN¥3.75 Billion
≈ $549.13 Million
CN¥756.12 Million
≈ $110.64 Million
0.201x -15.68%
2015-12-31 CN¥2.07 Billion
≈ $302.70 Million
CN¥494.32 Million
≈ $72.33 Million
0.239x -33.42%
2014-12-31 CN¥1.63 Billion
≈ $238.59 Million
CN¥585.19 Million
≈ $85.63 Million
0.359x -29.15%
2013-12-31 CN¥1.28 Billion
≈ $187.57 Million
CN¥649.34 Million
≈ $95.02 Million
0.507x +430.26%
2012-12-31 CN¥1.08 Billion
≈ $157.69 Million
CN¥102.95 Million
≈ $15.06 Million
0.096x -48.88%
2011-12-31 CN¥991.13 Million
≈ $145.03 Million
CN¥185.20 Million
≈ $27.10 Million
0.187x +264.74%
2010-12-31 CN¥844.15 Million
≈ $123.53 Million
CN¥-95.75 Million
≈ $-14.01 Million
-0.113x -247.73%
2009-12-31 CN¥750.98 Million
≈ $109.89 Million
CN¥-24.50 Million
≈ $-3.58 Million
-0.033x -110.54%
2008-12-31 CN¥723.47 Million
≈ $105.87 Million
CN¥223.91 Million
≈ $32.77 Million
0.309x +61.13%
2007-12-31 CN¥708.54 Million
≈ $103.68 Million
CN¥136.09 Million
≈ $19.91 Million
0.192x +13.34%
2006-12-31 CN¥605.80 Million
≈ $88.65 Million
CN¥102.66 Million
≈ $15.02 Million
0.169x +245.73%
2005-12-31 CN¥577.16 Million
≈ $84.46 Million
CN¥28.29 Million
≈ $4.14 Million
0.049x -63.17%
2004-12-31 CN¥609.02 Million
≈ $89.12 Million
CN¥81.06 Million
≈ $11.86 Million
0.133x +249.67%
2003-12-31 CN¥573.94 Million
≈ $83.99 Million
CN¥-51.04 Million
≈ $-7.47 Million
-0.089x -149.42%
2002-12-31 CN¥529.82 Million
≈ $77.53 Million
CN¥95.34 Million
≈ $13.95 Million
0.180x +369.42%
2001-12-31 CN¥517.19 Million
≈ $75.68 Million
CN¥-34.55 Million
≈ $-5.06 Million
-0.067x -123.55%
2000-12-31 CN¥344.80 Million
≈ $50.45 Million
CN¥97.80 Million
≈ $14.31 Million
0.284x +410.31%
1999-12-31 CN¥334.58 Million
≈ $48.96 Million
CN¥-30.58 Million
≈ $-4.48 Million
-0.091x +14.83%
1998-12-31 CN¥333.06 Million
≈ $48.74 Million
CN¥-35.74 Million
≈ $-5.23 Million
-0.107x --

About Jinyu Bio-Technology Co Ltd

SHG:600201 China Biotechnology
Market Cap
$2.01 Billion
CN¥13.72 Billion CNY
Market Cap Rank
#5931 Global
#1093 in China
Share Price
CN¥12.47
Change (1 day)
-1.03%
52-Week Range
CN¥10.50 - CN¥18.78
All Time High
CN¥30.02
About

Jinyu Bio-technology Co., Ltd. engages in the research and development, production, and sale of veterinary biological products in China and internationally. The company's products focus on preventing porcine mycoplasmal pneumonia, pseudorabies, highly pathogenic avian influenza, brucellosis, and other Class I, II, and III animal diseases. It also provides pig vaccines, swine foot-and-mouth diseas… Read more